Yes, I’ve ranted about healthcare prices before. On more than one occasion. But I have a new rant for you.
- It’s not about the high price of new drugs
- It’s not about a couple pharmo-bro CEOs hiking prices of generic medications by 4 or 5,000%
It’s about brand name drugs already on the market, that, instead of getting less expensive over time (due to increased competition, say, or increasing efficacy of production) get more expensive.
A team out of the University of Pittsburgh tracked the costs of drugs between 2008 and 2016, and discovered some truly disturbing trends.
(To read the rest of the article, please visit Forbes.)